(R) -Monlunabant
(R) -Monlunabant, also known as (R) -MRI-1891, is a selective CB1 receptor antagonist employed in preclinical research. It is utilized in both in vitro binding studies and in vivo animal models to investigate mechanisms related to obesity, metabolic syndrome, and associated cardiometabolic disorders.
Product Specifications
CAS Number
2765579-76-6
Field of Research
Pharmacology & Drug Discovery
Smiles
C (NS (=O) (=O) C1=CC=C (C (F) (F) F) C=C1) (=NC (NC (C) =O) =N) N2N=C ([C@@H] (C2) C3=CC=CC=C3) C4=CC=C (Cl) C=C4
Molecular Formula
C26H22ClF3N6O3S
Molecular Weight
591
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
040334-HRP 200 µL
PPP1CC, CT (PPP1CC, Serine/threonine-protein phosphatase PP1-gamma catalytic subunit, Protein phosphatase 1C catalytic subunit) (Azide free) (HRP) discontinued
Sign In for Pricing
View Details PC1019759-01 250 mg
1- (2,6-dichloro-4- (trifluoromethyl) phenyl) -2,2,2-trifluoroethanone
Sign In for Pricing
View Details PC1019759-02 500 mg
1- (2,6-dichloro-4- (trifluoromethyl) phenyl) -2,2,2-trifluoroethanone
Sign In for Pricing
View Details